Creating new methods to synthesize complex natural products
The Synthesis of Bioactive Natural Products as a Driving Force for Discovery in Organic Chemistry
This study is working on new ways to create important natural chemicals that can help develop better medicines, which could eventually lead to more effective treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | California Institute of Technology NIH-funded |
| Lab location | 1 site (Pasadena, United States) |
| Project ID | NIH-11055965 on NIH RePORTER |
What this research studies
This research focuses on developing innovative techniques for synthesizing complex bioactive molecules that are important in medicine. By optimizing new reaction methodologies, the project aims to create efficient pathways for producing essential chemical building blocks used in various natural products. The research will explore stereoselective reactions and transition metal-catalyzed processes to enhance the synthesis of these molecules, which could lead to advancements in drug development and other applications. Patients may benefit indirectly through improved access to new therapies derived from these bioactive compounds.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that could be treated by new bioactive compounds developed through these synthetic methods.
Not a fit: Patients who are not affected by conditions treatable with bioactive natural products may not receive any direct benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new medications and therapies derived from complex natural products.
How similar studies have performed: Other research in organic chemistry has shown success in developing new synthetic methodologies, suggesting that this approach has the potential for significant breakthroughs.
Where this research is happening
Pasadena, United States
- California Institute of Technology — Pasadena, United States (Active)
Researchers
- Principal investigator: Stoltz, Brian M — California Institute of Technology
- Study coordinator: Stoltz, Brian M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.